Syneos Health Inc - Class A
SYNH
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.46B
Close$
$43.99
2.3% upside
Current Fair Value
2.3% upsideUndervalued by 2.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.46 Billion |
|---|---|
| Enterprise Value | $8.07 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.57 |
| Beta | 1.58 |
| Outstanding Shares | 103,679,000 |
Return
| Return on Equity | 2.04% |
|---|---|
| Return on Assets | 0.88% |
| Return on Invested Capital | 5.18% |
Valuation & Multiples
| P/E Ratio | 16.72 |
|---|---|
| PEG | -16.9 |
| Price to Sales | 0.83 |
| Price to Book Ratio | 1.3 |
| Enterprise Value to Revenue | 1.49 |
| Enterprise Value to EBIT | 24.15 |
| Enterprise Value to Net Income | 113 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 1.06 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Syneos Health Inc
23,000 employees
CEO: Alistair Macdonald Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer perfor...